Physician profile
Matthew J Nykiel
NPI 1063612802
$180,742.83
in general payments reported to CMS, 2019-2025
12 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,440 · 2020: $22K · 2021: $167 · 2022: $7,123 · 2023: $39K · 2024: $82K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $58K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $41K · Travel and Lodging: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $1,822 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $58,300.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $40,875.00 |
| Travel and Lodging | $24,024.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,750.00 |
| Food and Beverage | $1,822.08 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $157,650.42 | 2019-2025 | |
| Apyx Medical Corporation | $20,914.40 | 2019-2020 | |
| Integra Lifesciences Corporation | $816.05 | 2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Motiva USA, LLC | $309.35 | 2025 | |
| Mentor Worldwide LLC | $308.54 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $299.36 | 2019-2022 | |
| Abbvie INC. | $173.60 | 2023-2025 | |
| Revance Therapeutics, INC. | $166.20 | 2025 | Daxxify |
| Vertex Pharmaceuticals Incorporated | $31.71 | 2025 | |
| Galderma Laboratories, L.P. | $25.98 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.83 | 2022 | |
| Merz North America, INC. | $23.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nykiel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.